FDA recall, , Moderate risk
Penn State Health Holy Spirit Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were distributed with incomplete testing.
Recall ended Sep 22, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Penn State Health Holy Spirit Medical Center began a recall of Red Blood Cells, Leukocytes Reduced on June 2, 2026, because the product was distributed with incomplete testing. The FDA added the recall to its Enforcement Report on September 22, 2026, and it was listed in the weekly enforcement report on September 30, 2026, for Pennsylvania.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Penn State Health Holy Spirit Medical Center
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99738
- Recall number
- B-0226-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
